(Total Views: 105)
Posted On: 04/03/2023 4:10:48 PM
Post# of 144752
$SNGX News Article - Soligenix Announces Scheduling of Type A Meeting with the U.S. FDA for HyBryte(TM) New Drug Application in the Treatment of Cutaneous T-Cell Lymphoma https://marketwirenews.com/news-releases/soli...35452.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
